Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study
Abstract Objectives Iguratimod, a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective against murine lupus. The aim of this study was to make a preliminary evaluation of the efficacy and safety of iguratimod as salvage therapy in patients with refractory lupus nephr...
Main Authors: | Yuening Kang, Qingran Yan, Qiong Fu, Ran Wang, Min Dai, Fang Du, Qing Dai, Ping Ye, Chunmei Wu, Liangjing Lu, Chunde Bao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-020-02154-7 |
Similar Items
-
Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
by: Qingran Yan, et al.
Published: (2023-03-01) -
Comparison of iguratimod and conventional cyclophosphamide with sequential azathioprine as treatment of active lupus nephritis: study protocol for a multi-center, randomized, controlled clinical trial (iGeLU study)
by: Qingran Yan, et al.
Published: (2021-08-01) -
Management of refractory lupus nephritis: challenges and solutions
by: Yo JH, et al.
Published: (2019-07-01) -
Treatment of refractory lupus nephritis using leflunomide: A prospective study
by: Shuo Zhang, et al.
Published: (2023-03-01) -
Telitacicept Treatment Refractory Lupus Nephritis: A Case Report
by: Sijia Li, et al.
Published: (2024-03-01)